Journal of Neurosurgical Sciences This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

One-year clinical and radiologic outcomes of Surpass Evolve flow diverter for large unruptured intracranial aneurysms
CONCLUSIONS: Surpass Evolve Flow Diverter seemed to be safe and effective for the treatment of dissecting/fusiform or complex aneurysms at one-year follow-up. However, further study is needed to evaluate long term results.PMID:38127302 | DOI:10.23736/S0390-5616.23.06161-1 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Hyun J Han Joonho Chung Chang K Jang Jung-Jae Kim Keun Y Park Yong B Kim Source Type: research

O-(2-18F- fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients
CONCLUSIONS: 18FET-PET can be a reliable tool to improve the selection of patients suitable for salvage surgery for glioblastoma recurrence.PMID:38127301 | DOI:10.23736/S0390-5616.23.06019-8 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Orazio S Santonocito Gianluca Grimod Anna L DI Stefano Francesco Pieri Mariagrazia Nizzola Nicola Mazzuca Francesco Pasqualetti Riccardo Morganti Vanna Zucchi Carlo Gambacciani Source Type: research

One-year clinical and radiologic outcomes of Surpass Evolve flow diverter for large unruptured intracranial aneurysms
CONCLUSIONS: Surpass Evolve Flow Diverter seemed to be safe and effective for the treatment of dissecting/fusiform or complex aneurysms at one-year follow-up. However, further study is needed to evaluate long term results.PMID:38127302 | DOI:10.23736/S0390-5616.23.06161-1 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Hyun J Han Joonho Chung Chang K Jang Jung-Jae Kim Keun Y Park Yong B Kim Source Type: research

O-(2-18F- fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients
CONCLUSIONS: 18FET-PET can be a reliable tool to improve the selection of patients suitable for salvage surgery for glioblastoma recurrence.PMID:38127301 | DOI:10.23736/S0390-5616.23.06019-8 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Orazio S Santonocito Gianluca Grimod Anna L DI Stefano Francesco Pieri Mariagrazia Nizzola Nicola Mazzuca Francesco Pasqualetti Riccardo Morganti Vanna Zucchi Carlo Gambacciani Source Type: research

One-year clinical and radiologic outcomes of Surpass Evolve flow diverter for large unruptured intracranial aneurysms
CONCLUSIONS: Surpass Evolve Flow Diverter seemed to be safe and effective for the treatment of dissecting/fusiform or complex aneurysms at one-year follow-up. However, further study is needed to evaluate long term results.PMID:38127302 | DOI:10.23736/S0390-5616.23.06161-1 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Hyun J Han Joonho Chung Chang K Jang Jung-Jae Kim Keun Y Park Yong B Kim Source Type: research

O-(2-18F- fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients
CONCLUSIONS: 18FET-PET can be a reliable tool to improve the selection of patients suitable for salvage surgery for glioblastoma recurrence.PMID:38127301 | DOI:10.23736/S0390-5616.23.06019-8 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Orazio S Santonocito Gianluca Grimod Anna L DI Stefano Francesco Pieri Mariagrazia Nizzola Nicola Mazzuca Francesco Pasqualetti Riccardo Morganti Vanna Zucchi Carlo Gambacciani Source Type: research

One-year clinical and radiologic outcomes of Surpass Evolve flow diverter for large unruptured intracranial aneurysms
CONCLUSIONS: Surpass Evolve Flow Diverter seemed to be safe and effective for the treatment of dissecting/fusiform or complex aneurysms at one-year follow-up. However, further study is needed to evaluate long term results.PMID:38127302 | DOI:10.23736/S0390-5616.23.06161-1 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Hyun J Han Joonho Chung Chang K Jang Jung-Jae Kim Keun Y Park Yong B Kim Source Type: research

O-(2-18F- fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients
CONCLUSIONS: 18FET-PET can be a reliable tool to improve the selection of patients suitable for salvage surgery for glioblastoma recurrence.PMID:38127301 | DOI:10.23736/S0390-5616.23.06019-8 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Orazio S Santonocito Gianluca Grimod Anna L DI Stefano Francesco Pieri Mariagrazia Nizzola Nicola Mazzuca Francesco Pasqualetti Riccardo Morganti Vanna Zucchi Carlo Gambacciani Source Type: research

One-year clinical and radiologic outcomes of Surpass Evolve flow diverter for large unruptured intracranial aneurysms
CONCLUSIONS: Surpass Evolve Flow Diverter seemed to be safe and effective for the treatment of dissecting/fusiform or complex aneurysms at one-year follow-up. However, further study is needed to evaluate long term results.PMID:38127302 | DOI:10.23736/S0390-5616.23.06161-1 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Hyun J Han Joonho Chung Chang K Jang Jung-Jae Kim Keun Y Park Yong B Kim Source Type: research

O-(2-18F- fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients
CONCLUSIONS: 18FET-PET can be a reliable tool to improve the selection of patients suitable for salvage surgery for glioblastoma recurrence.PMID:38127301 | DOI:10.23736/S0390-5616.23.06019-8 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Orazio S Santonocito Gianluca Grimod Anna L DI Stefano Francesco Pieri Mariagrazia Nizzola Nicola Mazzuca Francesco Pasqualetti Riccardo Morganti Vanna Zucchi Carlo Gambacciani Source Type: research

One-year clinical and radiologic outcomes of Surpass Evolve flow diverter for large unruptured intracranial aneurysms
CONCLUSIONS: Surpass Evolve Flow Diverter seemed to be safe and effective for the treatment of dissecting/fusiform or complex aneurysms at one-year follow-up. However, further study is needed to evaluate long term results.PMID:38127302 | DOI:10.23736/S0390-5616.23.06161-1 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Hyun J Han Joonho Chung Chang K Jang Jung-Jae Kim Keun Y Park Yong B Kim Source Type: research

O-(2-18F- fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients
CONCLUSIONS: 18FET-PET can be a reliable tool to improve the selection of patients suitable for salvage surgery for glioblastoma recurrence.PMID:38127301 | DOI:10.23736/S0390-5616.23.06019-8 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Orazio S Santonocito Gianluca Grimod Anna L DI Stefano Francesco Pieri Mariagrazia Nizzola Nicola Mazzuca Francesco Pasqualetti Riccardo Morganti Vanna Zucchi Carlo Gambacciani Source Type: research

One-year clinical and radiologic outcomes of Surpass Evolve flow diverter for large unruptured intracranial aneurysms
CONCLUSIONS: Surpass Evolve Flow Diverter seemed to be safe and effective for the treatment of dissecting/fusiform or complex aneurysms at one-year follow-up. However, further study is needed to evaluate long term results.PMID:38127302 | DOI:10.23736/S0390-5616.23.06161-1 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Hyun J Han Joonho Chung Chang K Jang Jung-Jae Kim Keun Y Park Yong B Kim Source Type: research

O-(2-18F- fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients
CONCLUSIONS: 18FET-PET can be a reliable tool to improve the selection of patients suitable for salvage surgery for glioblastoma recurrence.PMID:38127301 | DOI:10.23736/S0390-5616.23.06019-8 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Orazio S Santonocito Gianluca Grimod Anna L DI Stefano Francesco Pieri Mariagrazia Nizzola Nicola Mazzuca Francesco Pasqualetti Riccardo Morganti Vanna Zucchi Carlo Gambacciani Source Type: research

One-year clinical and radiologic outcomes of Surpass Evolve flow diverter for large unruptured intracranial aneurysms
CONCLUSIONS: Surpass Evolve Flow Diverter seemed to be safe and effective for the treatment of dissecting/fusiform or complex aneurysms at one-year follow-up. However, further study is needed to evaluate long term results.PMID:38127302 | DOI:10.23736/S0390-5616.23.06161-1 (Source: Journal of Neurosurgical Sciences)
Source: Journal of Neurosurgical Sciences - December 21, 2023 Category: Neurosurgery Authors: Hyun J Han Joonho Chung Chang K Jang Jung-Jae Kim Keun Y Park Yong B Kim Source Type: research